Avicanna Inc. AVCNF AVCN (FSE:0NN) has entered into a sponsorship agreement with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”) to sponsor CICC in making available and providing access to the Canadian Cannabis Syllabus (“CCS”), continuing education course accredited by the University of Calgary’s Office of Continuing Medical Education and Professional Development, available to the Canadian medical community.
“We are proud to be sponsoring CCIC who have championed the advancement of evidence-based research and education on the endocannabinoid system in Canada. In line with the launch of MyMedi.ca and our commitment to advance medical cannabis access, we believe that the CCS can be an effective tool to provide education for healthcare providers and provide information to support the adoption of medical cannabis by the medical community,” stated Dr. Karolina Urban, EVP of medical affairs at Avicanna.
Through the sponsorship agreement the CCS will be offered to healthcare providers interested in learning more about medical cannabis as a part of their practice. The CCS provides foundational knowledge and considerations for all healthcare professionals interested in learning more about cannabis and cannabinoid products in clinical practice.
The course consists of 9 modules including:
-
Introduction to the endocannabinoid system
-
Cannabis basics
-
Long-term health issues associated with cannabis
-
Clinical use of cannabis and cannabinoids in pain (3 modules)
-
Clinical use of cannabis in non-pain conditions
-
Considerations when authorizing cannabis
-
Acute adverse effects, drug interactions and contraindications of cannabis
-
Cannabis use disorder
-
Cannabis policy in Canada
Photo: Courtesy of Africa Studio on Shutterstock
Related News
Avicanna And Langara College Team Up For Cannabinoid-Based Translational Research
Shoppers Drug Mart Signs Definitive Cannabis Asset Sale Agreement With Avicanna\
These 3 Experts Will Help Regulate Rhode Island's Marijuana Market & Other Cannabis Appointments
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!